Literature DB >> 20572295

LPS removal from an E. coli fermentation broth using aqueous two-phase micellar system.

André M Lopes1, Pérola O Magalhães, Priscila G Mazzola, Carlota O Rangel-Yagui, João C M de Carvalho, Thereza C V Penna, Adalberto Pessoa.   

Abstract

In biotechnology, endotoxin (LPS) removal from recombinant proteins is a critical and challenging step in the preparation of injectable therapeutics, as endotoxin is a natural component of bacterial expression systems widely used to manufacture therapeutic proteins. The viability of large-scale industrial production of recombinant biomolecules of pharmaceutical interest significantly depends on the separation and purification techniques used. The aim of this work was to evaluate the use of aqueous two-phase micellar system (ATPMS) for endotoxin removal from preparations containing recombinant proteins of pharmaceutical interest, such as green fluorescent protein (GFPuv). Partition assays were carried out initially using pure LPS, and afterwards in the presence of E. coli cell lysate. The ATPMS technology proved to be effective in GFPuv recovery, preferentially into the micelle-poor phase (K(GFPuv) < 1.00), and LPS removal into the micelle-rich phase (%REM(LPS) > 98.00%). Therefore, this system can be exploited as the first step for purification in biotechnology processes for removal of higher LPS concentrations.
Copyright © 2010 American Institute of Chemical Engineers (AIChE).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20572295     DOI: 10.1002/btpr.463

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  6 in total

Review 1.  Preparative purification of recombinant proteins: current status and future trends.

Authors:  Mayank Saraswat; Luca Musante; Alessandra Ravidá; Brian Shortt; Barry Byrne; Harry Holthofer
Journal:  Biomed Res Int       Date:  2013-12-17       Impact factor: 3.411

Review 2.  Unnatural amino acid incorporation in E. coli: current and future applications in the design of therapeutic proteins.

Authors:  Kim Wals; Huib Ovaa
Journal:  Front Chem       Date:  2014-04-01       Impact factor: 5.221

3.  De Novo Biosynthesis of Apigenin, Luteolin, and Eriodictyol in the Actinomycete Streptomyces albus and Production Improvement by Feeding and Spore Conditioning.

Authors:  Laura Marín; Ignacio Gutiérrez-Del-Río; Paula Yagüe; Ángel Manteca; Claudio J Villar; Felipe Lombó
Journal:  Front Microbiol       Date:  2017-05-30       Impact factor: 5.640

4.  Optimized Triton X-114 assisted lipopolysaccharide (LPS) removal method reveals the immunomodulatory effect of food proteins.

Authors:  Malgorzata Teodorowicz; Olaf Perdijk; Iris Verhoek; Coen Govers; Huub F J Savelkoul; Yongfu Tang; Harry Wichers; Kerensa Broersen
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

Review 5.  Phage therapy: eco-physiological pharmacology.

Authors:  Stephen T Abedon
Journal:  Scientifica (Cairo)       Date:  2014-05-20

6.  Extracellular expression of glutamate decarboxylase B in Escherichia coli to improve gamma-aminobutyric acid production.

Authors:  Anqi Zhao; Xiaoqing Hu; Ye Li; Cheng Chen; Xiaoyuan Wang
Journal:  AMB Express       Date:  2016-08-22       Impact factor: 3.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.